# DeFi Capital Markets, Inc.: Form 10-Q for the period ended Sep 30, 2016

- Company: [DeFi Capital Markets, Inc.](/companies/dcm.md) (CIK 102109)
- Form: 10-Q
- Filed: 2016-12-02
- Accepted by EDGAR: Dec 2, 2016, 13:50 ET
- Period: 2016-09-30
- Accession: 0001144204-16-137640
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/102109/000114420416137640/v451869_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/102109/000114420416137640/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-07-01 to 2016-09-30 | $4.2m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2016-04-01 to 2016-09-30 | $7.4m | us-gaap:SalesRevenueGoodsNet |
| Gross profit | 3 months, 2016-07-01 to 2016-09-30 | $1.2m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2016-04-01 to 2016-09-30 | $2.3m | us-gaap:GrossProfit |
| Research and development | 3 months, 2016-07-01 to 2016-09-30 | $182.4k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2016-04-01 to 2016-09-30 | $320.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2016-07-01 to 2016-09-30 | $1.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2016-04-01 to 2016-09-30 | $2.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2016-07-01 to 2016-09-30 | −$90.6k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2016-04-01 to 2016-09-30 | −$279.0k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2016-07-01 to 2016-09-30 | −$64.1k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2016-04-01 to 2016-09-30 | −$453.7k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-07-01 to 2016-09-30 | −$0.03 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2016-04-01 to 2016-09-30 | −$0.20 | us-gaap:EarningsPerShareBasicAndDiluted |
| Cash and equivalents | at 2016-09-30 | $141.8k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-09-30 | $7.2m | us-gaap:AssetsCurrent |
| Total assets | at 2016-09-30 | $18.7m | us-gaap:Assets |
| Current liabilities | at 2016-09-30 | $3.1m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2016-09-30 | $15.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 19,853 characters.

As used throughout this Report, “we,” “our,” “the Company” “USI” and similar words refers to Universal Security Instruments, Inc.

### Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements reflecting our current expectations with respect to our operations, performance, financial condition, and other developments. These forward-looking statements may generally be identified by the use of the words “may”, “will”, “believes”, “should”, “expects”, “anticipates”, “estimates”, and similar expressions. These statements are necessarily estimates reflecting management’s best judgment based upon current information and involve a number of risks and uncertainties. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made, and readers are advised that various factors could affect our financial performance and could cause our actual results for future periods to differ materially from those anticipated or projected. While it is impossible to identify all such factors, such factors include, but are not limited to, those risks identified in our periodic reports filed with the Securities and Exchange Commission, including “Item 1A. Risk Factors” contained in recent Annual Reports on Form 10-K.

### overview

We are in the business of marketing and distributing safety and security products which are primarily manufactured through our 50%-owned Hong Kong Joint Venture. Our financial statements detail our sales and other operational results only, and report the financial results of the Hong Kong Joint Venture using the equity method. Accordingly, the following discussion and analysis of the three and six month periods ended September 30, 2016 and 2015 relate to the operational results of the Company. A discussion and analysis of the Hong Kong Joint Venture’s operational results for these periods is presented below under the heading “Joint Venture.”

The Company has developed new products based on new smoke and gas detection technologies, with what the Company believes are improved sensing technology and product features. To date we have applied for thirteen patents on these new technologies and features. We have been granted ten patents (including six for the new technologies and features), and are currently awaiting notification from the U.S. Patent Office regarding the three remaining patent applications. Most of our new technologies and features have been trademarked under the trade name IoPhic.

### Results of Operations

### Three Months Ended September 30, 2016 and 2015

*Sales.* Net sales for the three months ended September 30, 2016 were $4,213,705 compared to $3,278,225 for the comparable three months in the prior period, an increase of $935,480 (28.5%). The primary reason for the increase in net sales volumes relates to the introduction and sales of the Company’s new sealed product line.

*Gross Profit Margin.* Gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. Our gross profit margin was 29.6% and 20.9% of sales for the quarters ended September 30, 2016 and 2015, respectively. The increase in gross profit margin was primarily due to the higher margins realized on the Company’s new sealed product line.

*Expenses.* Selling, general and administrative expenses were $1,154,895 at September 30, 2016, compared to $1,153,830 for the comparable three months in the prior year. As a percentage of net sales, these expenses decreased to 27.4% for the three month period ended September 30, 2016, from 35.2% for the 2015 period. The decrease of these costs as a percentage of net sales was primarily due to higher net sales as compared to fixed expenses that do not increase directly with increased sales.

Research and development expenses were $182,352 for the three month period ended September 30, 2016 compared to $147,128 for the comparable quarter of the prior year, an increase of $35,224 (23.9%). The primary reasons for the increase is the increased expenditures to independent testing facilities as the new sealed product line is completed.

*Interest Expense and Other.* Our interest expense, is $24,549 for the quarter ended September 30, 2016, compared to interest expense of $4,701 for the quarter ended September 30, 2015. The net interest expense is dependent upon amounts borrowed from the Factor and from our Hong Kong Joint Venture netted against interest earned on balances maintained in an interest bearing account with our factor.

*Net Loss.* We reported a net loss of $64,066 for the quarter ended September 30, 2016, compared to a net loss of $411,302 for the corresponding quarter of the prior fiscal year, a $347,236 (84.4%) improvement in the net loss. The primary reasons for the decrease in net loss are the increase in sales due to the increased sales and gross profit margins realized on our new sealed product line, as explained above.

### Six Months Ended September 30, 2016 and 2015

*Sales.* Net sales for the six months ended September 30, 2016 were $7,392,312 compared to $6,214,715 for the comparable six months in the prior period, an increase of $1,177,597 (18.9%). The primary reason for the increase in net sales volumes relates to the introduction and sales of the Company’s new sealed product line.

*Gross Profit Margin.* The gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. The Company’s gross profit margin was 31.2% for the period ended September 30, 2016 and 25.2% for the period ended September 30, 2015. The increase in gross profit margin was primarily due to the higher margins realized on the Company’s new sealed product line.

*Expenses.* Selling, general and administrative expenses were $2,268,615 at September 30, 2016 compared to $2,317,616 for the comparable six months in the prior year. As a percentage of sales, these expenses were 30.7% for the six month period ended September 30, 2016 and 37.3% for the comparable 2015 period. The decrease of these costs as a percentage of net sales was primarily due to higher net sales as compared to fixed expenses that do not increase directly with increased sales.

Research and development expenses were $319,983 for the six months ended September 30, 2016 compared to $347,431 for the comparable period of the prior year, a decrease of $27,448 (7.9%). The primary reasons for the decrease is the slight reduction of expenditures to independent testing facilities during the six month period ended September 30, 2016 as the new sealed product line is completed.

*Interest Expense and Other.* Our interest expense was $28,785 for the six months ended September 30, 2016, compared to interest expense of $12,983 for the six months ended September 30, 2015. The net interest expense is dependent upon amounts borrowed from the Factor and from our Hong Kong Joint Venture netted against interest earned on balances maintained in an interest bearing account with our factor.

*Net Loss.* We reported a net loss of $453,745 for the six months ended September 30, 2016 compared to a net loss of $1,188,379 for the corresponding period of the prior fiscal year, an improvement in the net loss of $734,634 (61.8%). The primary reasons for the decrease in net loss are the increase in sales and gross profit margins realized due to the introduction of our new sealed product line with higher gross profit margins as explained above.

### Management Plans and Liquidity

The Company had net losses of $453,745 for the six months ended September 30, 2016, and $2,137,792 and $3,704,985 for the years ended March 31, 2016 and 2015, respectively. Furthermore, as of September 30, 2016, working capital (computed as the excess of current assets over current liabilities) decreased by $290,140 from $4,463,601 at March 31, 2016, to $4,173,461 at September 30, 2016.

Our short-term borrowings to finance operating losses, trade accounts receivable, and foreign inventory purchases are provided pursuant to the terms of our Factoring Agreement with Merchant. Advances from the Company’s factor, are at the sole discretion of Merchant based on their assessment of the Company’s receivables, inventory and financial condition at the time of each request for an advance. In addition, we have secured extended payment terms for purchases up to $2,000,000 from our Hong Kong Joint Venture for the purchase of the new sealed battery products. These amounts are unsecured, bear interest at 3.25%, and have repayment terms of ninety days for each advance thereunder. The combined availability of these facilities totaled approximately $2,091,000 at September 30, 2016.

The Company has a history of sales that are insufficient to generate profitable operations and has limited sources of financing. Management’s plan in response to these conditions includes increasing sales of the Company’s new line of sealed battery safety alarms, decreasing payroll expenses, and seeking additional financing on our existing credit facility. The Company has seen positive results on this plan during the fiscal year ended March 31, 2016 and through September 30, 2016 due to the increased sales of certain of its sealed battery products and reductions in payroll expense. Management expects sales growth to continue going forward. Though no assurances can be given, if management’s plan is successful over the next twelve months, the Company anticipates that it should be able to meet its cash needs. Cash flows and credit availability is expected to be adequate to fund operations for one year from the issuance date of these condensed consolidated financial statements.

Operating activities used cash of $570,036 for the six months ended September 30, 2016. This was primarily due to an increase in inventory and prepaid expenses of $911,794 and a net loss of $453,745. This was partially offset by increases of $596,591 in accounts payable and accrued expenses, and a loss from the investment in the Hong Kong Joint Venture of $145,972. For the same period last year, operating activities used cash of $1,533,523, primarily as a result of the net loss of $1,188,379, increases in accounts receivable and amounts due from factor of $217,597, increases in inventory and prepaid expenses of $535,233, and partially offset by an increase in accounts payable and accrued expenses of $311,484.

Investing activities did not use or provide cash during the six months ended September 30, 2016. Investing activities provided cash of $631,906 during the six months ended September 30, 2015 as a result of the withdrawal of interest bearing funds held by the factor.

Financing activities provided cash of $349,100 during the six months ended September 30, 2016 and provided cash of $1,001,007 during the three months ended September 30, 2015, which is comprised of advances net of repayments on the line of credit from our factor.

### Joint Venture

*Net Sales.* Net sales of the Joint Venture for the three and six months ended September 30, 2016 were $4,789,764 and $8,273,094 respectively, compared to $5,624,057 and $10,236,562, respectively, for the comparable period in the prior fiscal year. The 14.8% and 19.2% respective decreases in net sales by the Joint Venture for the three and six month periods are due to lower sales to unaffiliated customers primarily in Europe.

*Gross Profit Margin.* Gross margins of the Joint Venture for the three month period ended September 30, 2016 decreased to 31.3% from 32.9% for the 2015 corresponding period. For the six month period ended September 30, 2016, gross margins were 26.7% compared to 21.6% for the same period of the prior year. Gross margins depend on sales volume of various products, with varying margins, accordingly, increased sales of higher margin products and decreased sales of lower margin products positively affect the overall gross margins.

*Expenses.* Selling, general and administrative expenses were $1,129,972 and $2,107,265, respectively, for the three and six month periods ended September 30, 2016, compared to $1,138,359 and $2,347,535 in the prior year’s respective periods. As a percentage of sales, expenses were 23.6% and 25.5% for the three and six month periods ended September 30, 2016, compared to 20.2% and 22.9% for the three and six month periods ended September 30, 2015. The changes in selling, general and administrative expense as a percent of sales for the three and six month periods were primarily due to costs that do not change at the same rate as changes in sales volume.

*Interest Income.* Interest income on assets held for investment was $106,763 and $204,717 respectively, for the three and six month periods ended September 30, 2016, compared to interest income of $113,049 and $229,619, respectively, for the prior year’s periods. Interest income is dependent on the average balance of assets held for investment.

*Net Income (Loss)*. Net earnings for the three and six months ended September 30, 2016 were $412,603 and $206,427, respectively, compared to net earnings (loss) of $761,848 and $(23,079), respectively, in the comparable periods last year. The decrease in net earnings for the three month period ended September 30, 2016 are due primarily to decreased sales volume for the joint venture as noted above. The increase in net income for the six month period of the current year is due primarily to a reduction in selling, general and administrative costs and improved gross profit margins realized during the six month period ended September 30, 2016.

*Liquidity.* Cash needs of the Joint Venture are currently met by funds generated from operations. During the six months ended September 30, 2016, working capital increased by $2,538,414 from $6,144,962 on March 31, 2016 to $8,683,376 on September 30, 2016.

### Critical Accounting Policies

Management’s discussion and analysis of our condensed consolidated financial statements and results of operations are based on our condensed Consolidated Financial Statements included as part of this document. The preparation of these condensed consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate these estimates, including those related to bad debts, inventories, income taxes, and contingencies and litigation. We base these estimates on historical experiences, future projections and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We believe the following critical accounting policies affect management’s more significant judgments and estimates used in the preparation of its condensed consolidated financial statements. For a detailed discussion on the application on these and other accounting policies, see Note A to the consolidated financial statements included in Item 8 of the Form 10-K for the year ended March 31, 2016 as filed with the Securities and Exchange Commission on September 28, 2016. Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty and actual results could differ from these estimates. These judgments are based on our historical experience, terms of existing contracts, current economic trends in the industry, information provided by our customers, and information available from outside sources, as appropriate. Our critical accounting policies include:

*Revenue Recognition.* The Company recognizes sales upon shipment of products, when title has passed to the buyer, net of applicable provisions for any discounts or allowances. We recognize revenue when the following criteria are met: evidence of an arrangement exists; fixed and determinable fee; delivery has taken place; and collectability is reasonably assured. Customers may not return, exchange or refuse acceptance of goods without our approval. However, the Company has entered into an agreement with a customer to grant pre-approved rights of return of up to fifty percent of products sold on certain invoices to provide for and gain acceptance within certain markets. When a pre-approved right of return is granted, revenue recognition is deferred until the right of return expires. We have established allowances to cover anticipated doubtful accounts based upon historical experience.

*Inventories.* Inventories are valued at the lower of cost or market. Cost is determined on the first-in first-out method. We evaluate inventories on a quarterly basis and write down inventory that is deemed obsolete or unmarketable in an amount equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions.

*Income Taxes.* The Company recognizes a liability or asset for the deferred tax consequences of temporary differences between the tax basis of assets or liabilities and their reported amounts in the consolidated financial statements. These temporary differences may result in taxable or deductible amounts in future years when the reported amounts of the assets or liabilities are recovered or settled. The deferred tax assets are reviewed periodically for recoverability and a valuation allowance is provided whenever it is more likely than not that a deferred tax asset will not be realized. After a review of projected taxable income and the components of the deferred tax asset in accordance with applicable accounting guidance it was determined that it is more likely than not that the tax benefits associated with the remaining components of the deferred tax assets will not be realized. This determination was made based on the Company’s recent history of losses from operations and the uncertainty as to whether the Company will generate sufficient taxable income to use the deferred tax assets prior to their expiration.

Accordingly, a valuation allowance was established to fully offset the value of the deferred tax assets. Our ability to realize the tax benefits associated with the deferred tax assets depends primarily upon the timing of future taxable income and the expiration dates of the components of the deferred tax assets. If sufficient future taxable income is generated, we may be able to offset a portion of future tax expenses.

The Company follows ASC 740-10 that gives guidance to tax positions related to the recognition and measurement of a tax position taken or expected to be taken in a tax return and requires that we recognize in our financial statements the impact of a tax position, if that position is more likely than not to be sustained upon an examination, based on the technical merits of the position. Interest and penalties, if any, related to income tax matters are recorded as income tax expenses.

*Off-Balance Sheet Arrangements.* We have not created, and are not party to, any special-purpose or off balance sheet entities for the purpose of raising capital, incurring debt or operating parts of our business that are not consolidated into our condensed financial statements and do not have any arrangements or relationships with entities that are not consolidated into our condensed financial statements that are reasonably likely to materially affect our liquidity or the availability of our capital resources.

## Controls and procedures

As filed, 1,735 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures (as such item is defined in Rules 13a – 15(e) and 15d – 15(e) of the Exchange Act) that is designed to provide reasonable assurance that information, which is required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and is accumulated and communicated to management in a timely manner. Our Chief Executive Officer and Chief Financial Officer have evaluated this system of disclosure controls and procedures in accordance with applicable Securities and Exchange Commission guidance as of the end of the period covered by this quarterly report, and have concluded that disclosure controls and procedures were not effective because of the material weakness in internal control over financial reporting as discussed below.

Material weaknesses arose in our oversight of the accounting function and disclosure controls and procedures of the Hong Kong Joint Venture (HKJV). The HKJV is a material component of the Company’s consolidated financial statements. The Company has discussed this weakness with management of the HKJV and is monitoring implementation of suggested improvements.

***Changes in Internal Control over Financial Reporting***. There have not been any changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed Dec 2, 2016.
Source: SEC EDGAR, the filing index for accession 0001144204-16-137640. Last ingested by Listed: Nov 4, 2026, 06:09 ET. No prices; not investment advice.
